Mounjaro®
Starting from £179.99/mo
Start journey Learn moreA tirzepatide injection home kit covers everything you need to self-inject safely outside a clinical setting: the pre-filled Mounjaro KwikPen, a fresh needle for each dose, alcohol swabs to clean the injection site, and a sharps container for disposal. Getting these basics right from the start matters far more than most people expect. Tirzepatide is a prescription-only medicine — a GPhC-registered prescriber assesses your suitability before any treatment begins, so the equipment discussion is just one part of a supervised process. Learn more about the tirzepatide injection itself to understand how the pen works before you open your first kit.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The Mounjaro KwikPen arrives ready to use. It's a pre-filled, single-strength pen, so a 5 mg pen delivers 5 mg per dose for all four doses it holds; there's no mixing, no drawing up, no dialling. That simplicity is deliberate, but it doesn't mean no preparation is needed. Alongside the pen itself, you'll want a compatible needle (the pen uses a standard 4 mm or 5 mm pen needle), an alcohol swab for each injection, and a suitable sharps container kept within reach. The pen comes with a Patient Information Leaflet inside the box; read it in full before your first injection. The Mounjaro KwikPen overview on our site walks through the physical parts of the device if you want to familiarise yourself before you start. Many people find it reassuring to lay everything out on a clean surface before they begin, a small habit that cuts down on fumbling mid-injection.
There are three licensed injection sites: the abdomen (at least a few centimetres from your navel), the front or outer thigh, and the back of the upper arm. Rotating between sites week by week reduces the chance of localised skin reactions, hardening, dimpling or tenderness at the same spot. If you inject into the same square centimetre every week, the tissue changes over time and absorption can become unpredictable. A simple pattern helps: abdomen one week, thigh the next, upper arm after that. The injection technique guide covers the pinch-lift method and angle in more detail. Avoid skin that is bruised, broken, inflamed or scarred. For most people, the abdomen is the easiest starting point because you can see exactly what you're doing, the upper arm tends to require a bit of practice or a second pair of hands. The full home injection walkthrough runs through each site with step-by-step instructions.
Mild redness, a small welt or temporary bruising at the needle point is normal and usually clears within a day or two. Rotating sites, as above, keeps these reactions minor. What does warrant attention is persistent swelling, spreading redness, warmth or pain that gets worse rather than better over 48 hours, those signs suggest a skin reaction that needs a prescriber's eye. Systemic side effects from tirzepatide are mostly gastrointestinal: nausea, loose stools, constipation, reflux, or burping. These tend to peak in the first week or two after a new dose and ease as your body adjusts, according to the NHS medicines information for tirzepatide. If you experience severe, persistent stomach pain that radiates towards your back, seek medical help promptly, the MHRA flagged acute pancreatitis as an infrequent but serious risk with GLP-1 medicines in a January 2026 Drug Safety Update. You can report any suspected side effects at the MHRA Yellow Card scheme. Our aftercare team is available seven days a week if something feels off between consultations.
This is the part of a home kit that catches people out. A used pen needle is a clinical sharp, it cannot go into a household bin or recycling box. The correct route is an approved sharps container (a rigid, puncture-resistant yellow box), disposed of via your local council's sharps collection service or a pharmacy collection point. Local councils vary on how they handle residential sharps, most offer a collection or drop-off scheme, and your GP surgery or local pharmacy can advise on what's available in your area. The pen body itself, once all four doses are used, goes into the sharps container too. Keep the container out of reach of children and away from direct heat. It is worth sorting this before your first injection, not after, trying to track down a sharps service on a weekday afternoon, before the school run ends, is exactly the kind of thing that puts people off a good routine. For context on what pen needles are compatible with the Mounjaro KwikPen, including sizing, see our dedicated needle guide. Once your kit is in order and you've had your consultation, the treatment options page explains the full care pathway from prescription to delivery. The cost side of treatment is covered on the Mounjaro pricing page if that's a question on your mind.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.